Literature DB >> 17409222

Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction.

Stephanie Jacks1, Steeve Giguère, P Cynda Crawford, William L Castleman.   

Abstract

Rhodococcus equi is a facultative intracellular pathogen that causes pneumonia in young foals but does not induce disease in immunocompetent adult horses. Clearance of R. equi depends mainly on gamma interferon (IFN-gamma) production by T lymphocytes, whereas the predominance of interleukin 4 (IL-4) is detrimental. Young foals, like neonates of many other species, are generally deficient in the ability to produce IFN-gamma. The objective of this study was to compare the cytokine profiles, as well as cell-mediated and antibody responses, of young foals to those of adult horses following intrabronchial challenge with R. equi. The lymphoproliferative responses of bronchial lymph node (BLN) cells to concanavalin A were significantly higher in foals than in adult horses. In contrast, adult horses had significantly higher lymphoproliferative responses to R. equi antigens than did foals. Infected foals had significantly lower IL-4 mRNA expression but significantly higher IFN-gamma expression and IFN-gamma/IL-4 ratio in R. equi-stimulated BLN lymphocytes than did infected adults. Infection with R. equi in foals resulted in a significant increase in the percentage of T lymphocytes and CD4(+) T lymphocytes in bronchoalveolar lavage fluid in association with a significant decrease in the percentage of these cell populations in BLNs. Infection of foals also resulted in a marked increase in serum immunoglobulin Ga (IgGa) and IgGb levels, resulting in concentrations in serum that were significantly higher than those of adult horses. This study demonstrates that the immune response to R. equi in foals is not biased toward IL-4 and is characterized by the predominant induction of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409222      PMCID: PMC1951072          DOI: 10.1128/CVI.00042-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  47 in total

1.  DNA sequence and comparison of virulence plasmids from Rhodococcus equi ATCC 33701 and 103.

Authors:  S Takai; S A Hines; T Sekizaki; V M Nicholson; D A Alperin; M Osaki; D Takamatsu; M Nakamura; K Suzuki; N Ogino; T Kakuda; H Dan; J F Prescott
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  Immunity to Rhodococcus equi: antigen-specific recall responses in the lungs of adult horses.

Authors:  M T Hines; K M Paasch; D C Alperin; G H Palmer; N C Westhoff; S A Hines
Journal:  Vet Immunol Immunopathol       Date:  2001-05-10       Impact factor: 2.046

3.  IgE and IgG antibodies in skin allergy of the horse.

Authors:  Bettina Wagner; William H Miller; Erin E Morgan; Julia M Hillegas; Hollis N Erb; Wolfgang Leibold; Douglas F Antczak
Journal:  Vet Res       Date:  2006-09-15       Impact factor: 3.683

4.  Neonatal bacillus Calmette-Guérin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes.

Authors:  J Vekemans; A Amedei; M O Ota; M M D'Elios; T Goetghebuer; J Ismaili; M J Newport; G Del Prete; M Goldman; K P McAdam; A Marchant
Journal:  Eur J Immunol       Date:  2001-05       Impact factor: 5.532

5.  Immunoglobulin isotypes in sera and nasal mucosal secretions and their neonatal transfer and distribution in horses.

Authors:  A S Sheoran; J F Timoney; M A Holmes; S S Karzenski; M V Crisman
Journal:  Am J Vet Res       Date:  2000-09       Impact factor: 1.156

6.  Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia.

Authors:  K E Hooper-McGrevy; S Giguere; B N Wilkie; J F Prescott
Journal:  Am J Vet Res       Date:  2001-08       Impact factor: 1.156

7.  Application of Sartwell's model (lognormal distribution of incubation periods) to age at onset and age at death of foals with Rhodococcus equi pneumonia as evidence of perinatal infection.

Authors:  M L Horowitz; N D Cohen; S Takai; T Becu; M K Chaffin; K K Chu; K G Magdesian; R J Martens
Journal:  J Vet Intern Med       Date:  2001 May-Jun       Impact factor: 3.333

8.  Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination.

Authors:  Martin O C Ota; Johan Vekemans; Susanna E Schlegel-Haueter; Katherine Fielding; Mariama Sanneh; Michael Kidd; Melanie J Newport; Peter Aaby; Hilton Whittle; Paul-Henri Lambert; Keith P W J McAdam; Claire-Anne Siegrist; Arnaud Marchant
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

9.  A novel lipoarabinomannan from the equine pathogen Rhodococcus equi. Structure and effect on macrophage cytokine production.

Authors:  Natalie J Garton; Martine Gilleron; Thérèse Brando; Han-Hong Dan; Steeve Giguère; Germain Puzo; John F Prescott; Iain C Sutcliffe
Journal:  J Biol Chem       Date:  2002-06-18       Impact factor: 5.157

10.  Characterization of peripheral blood and pulmonary leukocyte function in healthy foals.

Authors:  M J Flaminio; B R Rush; E G Davis; K Hennessy; W Shuman; M J Wilkerson
Journal:  Vet Immunol Immunopathol       Date:  2000-03-15       Impact factor: 2.046

View more
  11 in total

1.  Early development of cytotoxic T lymphocytes in neonatal foals following oral inoculation with Rhodococcus equi.

Authors:  Seth P Harris; Melissa T Hines; Robert H Mealey; Debra C Alperin; Stephen A Hines
Journal:  Vet Immunol Immunopathol       Date:  2011-03-21       Impact factor: 2.046

2.  Equine neonates have attenuated humoral and cell-mediated immune responses to a killed adjuvanted vaccine compared to adult horses.

Authors:  Clare Ryan; Steeve Giguère
Journal:  Clin Vaccine Immunol       Date:  2010-10-13

3.  Detection of virulent Rhodococcus equi in exhaled air samples from naturally infected foals.

Authors:  G Muscatello; J R Gilkerson; G F Browning
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

4.  Interferon-gamma, interleukin-4 and interleukin-10 production by T helper cells reveals intact Th1 and regulatory TR1 cell activation and a delay of the Th2 cell response in equine neonates and foals.

Authors:  Bettina Wagner; Alexandra Burton; Dorothy Ainsworth
Journal:  Vet Res       Date:  2010-04-09       Impact factor: 3.683

5.  Foal monocyte-derived dendritic cells become activated upon Rhodococcus equi infection.

Authors:  M Julia B F Flaminio; Daryl V Nydam; Hélène Marquis; Mary Beth Matychak; Steeve Giguère
Journal:  Clin Vaccine Immunol       Date:  2008-12-24

6.  Regulatory T cells in early life: comparative study of CD4+CD25high T cells from foals and adult horses.

Authors:  Eman Hamza; Jelena Mirkovitch; Falko Steinbach; Eliane Marti
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

7.  Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate.

Authors:  Rebecca L Tallmadge; Steven C Miller; Stephen A Parry; Maria Julia B Felippe
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

8.  Age-related changes following in vitro stimulation with Rhodococcus equi of peripheral blood leukocytes from neonatal foals.

Authors:  Priyanka Kachroo; Ivan Ivanov; Ashley G Seabury; Mei Liu; Bhanu P Chowdhary; Noah D Cohen
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

9.  Effects of Separate and Concomitant TLR-2 and TLR-4 Activation in Peripheral Blood Mononuclear Cells of Newborn and Adult Horses.

Authors:  Johannes Cornelis Vendrig; Luc Edgar Coffeng; Johanna Fink-Gremmels
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

10.  Oral Administration of Electron-Beam Inactivated Rhodococcus equi Failed to Protect Foals against Intrabronchial Infection with Live, Virulent R. equi.

Authors:  Joana N Rocha; Noah D Cohen; Angela I Bordin; Courtney N Brake; Steeve Giguère; Michelle C Coleman; Robert C Alaniz; Sara D Lawhon; Waithaka Mwangi; Suresh D Pillai
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.